Blood salvage and autotransfusion during orthotopic liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis.

David Eugenio Hinojosa-Gonzalez Gustavo Salgado-Garza Eduardo Tellez-Garcia Jaime A Escarcega-Bordagaray Luis Carlos Bueno-Gutierrez Katheryne Madrazo-AguirreMonica I Muñoz-HibertKarla G Diaz-GarzaIsabela Ramírez-MulhernRodrigo Alvarez de la Reguera-BabbEduardo Flores-VillalbaMario Rodarte-Shade Mauricio Gonzalez-Urquijo

Published in: Clinical transplantation (2023)

IBS-AT use is not associated with increased risk of recurrence in liver transplant for HCC even without leukocyte filtration. Both operative and postoperative outcomes are similar between groups. Comparison of analyzed studies suggest that IBS-AT is safe for use during liver transplant for HCC.

Keyphrases

irritable bowel syndrome
patients undergoing
case control
adipose tissue